Monocyte dipeptidyl peptidase 4 activity is associated with urinary albumin excretion in type 2 diabetes
Hideyuki Okuma, Takahiro Tsutsumi, Kyoichiro Tsuchiya · 2026
Read Monocyte dipeptidyl peptidase 4 activity is associated with urinary albumin excretion in type 2 diabetes by Hideyuki Okuma, Takahiro Tsutsumi, Kyoichiro Tsuchiya (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13398444.txt.
Description
Hideyuki Okuma, Takahiro Tsutsumi and Kyoichiro Tsuchiya ask whether an enzyme on white blood cells tracks kidney damage in type 2 diabetes. Their 2026 study enrols 64 patients with diabetes who take no incretin-based drugs, plus 50 healthy controls taking nothing. Dipeptidyl peptidase 4, or DPP4, and inflammatory genes in monocytes had each been tied to diabetic kidney disease, but the monocyte link itself was untested.
Monocytes were isolated, cultured and challenged with a bacterial signal, then assayed for DPP4 gene activity, enzyme action and inflammatory gene output. Kidney standing was graded by urine albumin ratios and filtration estimates. Tying the cell measures to those kidney readings tests whether monocyte DPP4 could flag patients sliding toward renal harm.
Catalog record
| CREATOR | Hideyuki Okuma, Takahiro Tsutsumi, Kyoichiro Tsuchiya |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 50670 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |